每經(jing)AI快(kuai)訊，邁(mai)克生物（SZ 300463，收盤價：14.18元(yuan)(yuan)）10月(yue)(yue)26日(ri)發布公(gong)(gong)(gong)(gong)(gong)告稱，截至本公(gong)(gong)(gong)(gong)(gong)告日(ri)，公(gong)(gong)(gong)(gong)(gong)司(si)(si)及控(kong)(kong)股子(zi)(zi)公(gong)(gong)(gong)(gong)(gong)司(si)(si)對(dui)外(wai)(wai)擔(dan)(dan)保(bao)(bao)額度(du)總金額為(wei)14.3億(yi)(yi)元(yuan)(yuan)人(ren)(ren)民(min)幣，占(zhan)公(gong)(gong)(gong)(gong)(gong)司(si)(si)2022年(nian)(nian)(nian)12月(yue)(yue)31日(ri)經(jing)審(shen)(shen)計(ji)(ji)凈資產(chan)(chan)的(de)比(bi)(bi)(bi)例(li)(li)(li)為(wei)22.72%，公(gong)(gong)(gong)(gong)(gong)司(si)(si)及控(kong)(kong)股子(zi)(zi)公(gong)(gong)(gong)(gong)(gong)司(si)(si)實(shi)際對(dui)外(wai)(wai)擔(dan)(dan)保(bao)(bao)余額約(yue)4.5億(yi)(yi)元(yuan)(yuan)人(ren)(ren)民(min)幣，占(zhan)公(gong)(gong)(gong)(gong)(gong)司(si)(si)2022年(nian)(nian)(nian)12月(yue)(yue)31日(ri)經(jing)審(shen)(shen)計(ji)(ji)凈資產(chan)(chan)的(de)比(bi)(bi)(bi)例(li)(li)(li)為(wei)7.15%；公(gong)(gong)(gong)(gong)(gong)司(si)(si)對(dui)子(zi)(zi)公(gong)(gong)(gong)(gong)(gong)司(si)(si)的(de)擔(dan)(dan)保(bao)(bao)額度(du)總金額為(wei)9.3億(yi)(yi)元(yuan)(yuan)人(ren)(ren)民(min)幣，占(zhan)公(gong)(gong)(gong)(gong)(gong)司(si)(si)2022年(nian)(nian)(nian)12月(yue)(yue)31日(ri)經(jing)審(shen)(shen)計(ji)(ji)凈資產(chan)(chan)的(de)比(bi)(bi)(bi)例(li)(li)(li)為(wei)14.78%實(shi)際對(dui)子(zi)(zi)公(gong)(gong)(gong)(gong)(gong)司(si)(si)擔(dan)(dan)保(bao)(bao)余額為(wei)6522.77萬元(yuan)(yuan)人(ren)(ren)民(min)幣，占(zhan)公(gong)(gong)(gong)(gong)(gong)司(si)(si)2022年(nian)(nian)(nian)12月(yue)(yue)31日(ri)經(jing)審(shen)(shen)計(ji)(ji)凈資產(chan)(chan)的(de)比(bi)(bi)(bi)例(li)(li)(li)為(wei)1.04%；公(gong)(gong)(gong)(gong)(gong)司(si)(si)對(dui)外(wai)(wai)擔(dan)(dan)保(bao)(bao)額度(du)總金額為(wei)5億(yi)(yi)元(yuan)(yuan)，占(zhan)公(gong)(gong)(gong)(gong)(gong)司(si)(si)2022年(nian)(nian)(nian)12月(yue)(yue)31日(ri)經(jing)審(shen)(shen)計(ji)(ji)凈資產(chan)(chan)的(de)比(bi)(bi)(bi)例(li)(li)(li)為(wei)7.94%，實(shi)際對(dui)外(wai)(wai)擔(dan)(dan)保(bao)(bao)余額為(wei)3.85億(yi)(yi)元(yuan)(yuan)人(ren)(ren)民(min)幣，占(zhan)公(gong)(gong)(gong)(gong)(gong)司(si)(si)2022年(nian)(nian)(nian)12月(yue)(yue)31日(ri)經(jing)審(shen)(shen)計(ji)(ji)凈資產(chan)(chan)的(de)比(bi)(bi)(bi)例(li)(li)(li)為(wei)6.12%。

2023年1至6月份，邁克生(sheng)物(wu)的營業收入(ru)構成為：體外診斷占(zhan)比(bi)100.0%。

邁克生(sheng)物的董事長是唐勇，男，60歲，學(xue)(xue)歷背(bei)景(jing)(jing)為大(da)專；總(zong)經理是吳(wu)明建(jian)，男，48歲，學(xue)(xue)歷背(bei)景(jing)(jing)為碩(shuo)士。

道達(da)號(hao)（daoda1997）“個股趨勢”提醒：
1. 邁克生物近30日內北向資金持股量增加55.27萬股，占流通股比例增加0.12%；
2. 近30日內無機構對邁克生物進行調研。
更(geng)多個股趨勢信息(xi)，請搜索微信公眾號(hao)“道達號(hao)”，回復“查(cha)詢”，領取免費查(cha)詢權(quan)限(xian)！

每經(jing)頭(tou)條（nbdtoutiao）——

(記者 蔡鼎)

免責(ze)聲明：本文內(nei)容與數據僅供參考(kao)，不構成投資建議，使用前請核實。據此(ci)操作，風險自擔。